STOCK TITAN
  1. Home
  2. Sec-filings
  3. MDGL
  4. [Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity

[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity

Filing Impact
(Moderate)
Filing Sentiment
(Negative)
Form Type
4
Rhea-AI Filing Summary
Analyzing...
Positive
  • None.
Negative
  • None.

Insights

Analyzing...

Filing content is currently unavailable.

Source: View Original Filing on SEC EDGAR

Stock MDGL logo
Madrigal Pharmac

NASDAQ:MDGL

MDGL Rankings

#1482 Ranked by Market Cap
N/A Ranked by Dividends

MDGL Latest News

Jul 22, 2025
Madrigal Pharmaceuticals Secures $500 Million in Senior Secured Credit from Blue Owl Managed Funds to Further Extend Leadership Position in MASH
Jul 16, 2025
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
Jul 16, 2025
Madrigal Pharmaceuticals Receives Notice of Allowance from U.S. Patent and Trademark Office for New U.S. Patent Covering Rezdiffra™ (Resmetirom)
Jun 20, 2025
Madrigal Receives Positive CHMP Opinion for Resmetirom (Rezdiffra™) for the Treatment of MASH with Moderate to Advanced Liver Fibrosis
Jun 17, 2025
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)

MDGL Latest SEC Filings

Jul 22, 2025
[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity
Jul 22, 2025
[8-K] Madrigal Pharmaceuticals, Inc. Reports Material Event
Jul 18, 2025
[144] Madrigal Pharmaceuticals, Inc. SEC Filing
Jul 18, 2025
[144] Madrigal Pharmaceuticals, Inc. SEC Filing
Jul 18, 2025
[Form 4] Madrigal Pharmaceuticals, Inc. Insider Trading Activity

MDGL Stock Data

6.91B
20.43M
8.74%
105.1%
17%
Biotechnology
Pharmaceutical Preparations
Link
United States
WEST CONSHOHOCKEN